OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Quick
Links
More Charts
Credit Tracker By Industry Sector
Credit Tracker By Sector
Credit ratings are not currently available for public cannabis companies leaving companies, lenders and investors with a gap of information. The Viridian Cannabis Credit Tracker fills this gap. The model uses 11 market and financial statement variables to discern 4 key credit factors: Liquidity, Leverage, Profitability, and Size, to provide credit/liquidity analysis for over 370 public Cannabis/Hemp companies.
Week ended 08/11/2023
We continue to be concerned about the critically weak liquidity in the psychedelics sector. The median current ratio of the 25 companies in the sector is a deceptively strong 3.41x; however, the industry is heavily negative cash flow from operations, funding operating costs, and the costs of clinical trials. Considering this, the median free cash flow adjusted current ratio is -0.59x, indicating severe liquidity stress. The 1st quartile figure of -1.51x is the lowest among the 12 sectors we track. Only the top eight companies will be fully funded through the following year.
Week ended 08/11/2023
We continue to be concerned about the critically weak liquidity in the psychedelics sector. The median current ratio of the 25 companies in the sector is a deceptively strong 3.41x; however, the industry is heavily negative cash flow from operations, funding operating costs, and the costs of clinical trials. Considering this, the median free cash flow adjusted current ratio is -0.59x, indicating severe liquidity stress. The 1st quartile figure of -1.51x is the lowest among the 12 sectors we track. Only the top eight companies will be fully funded through the following year.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
